ACTRN12621001128886终止未知
Effect of pharmacist involvement in Diabetes Medication Therapy Adherence Program (DMTAC) on the clinical outcomes in type 2 diabetes mellitus - a multicentre randomised control trial
Muhammad Zahid Iqbl0 个研究点目标入组 299 人开始时间: 2021年8月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 发起方
- 入组人数
- 299
研究概览
简要总结
This section not yet completed
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 30 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients who are having Diabetes mellitus since a minimum of 5 years and HbA1c more than 8.0% and receiving medicine from any selected hospital. Total 200 patients required in each selected hospital and from those 200 patients 100 will be taken from Diabetic clinics and 100 will be taken from DMTAC clinics
排除标准
- •Pregnant diabetic patients, HIV / cancer patients, Incomplete Patient Record,Children with CKD, Newly diagnosed patients
研究者
相似试验
已完成
Unknown
The outcome of a clinical pharmacist-led diabetes education initiative in type II diabetes mellitus patientsdiabetesPACTR202311766174946self sponsored322
已完成
不适用
The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes Mellitus.Type 2 Diabetes Mellitus (T2DM)NCT06719661University of Sulaimani138
已完成
不适用
Impact of Pharmacist in Cardiology ServiceCardiomyopathy, DiabeticNCT03206294Fondation Hôpital Saint-Joseph44
已完成
不适用
Impact of Pharmaceutical Care in Diabetics PatientsDiabetes Mellitus Type 2NCT01580904Universidade Estadual da Paraiba100
已完成
3 期
Impacts of pharmacist's medication care in diabeticIRCT20150706023084N20Islamic Azad University60